Search results
In the current review we discuss the appropriate definition of very high-risk prostate cancer and recent advancements in the treatment of these patients, focusing primarily on those with locally advance disease (clinical stage T3b-T4) and lymph node metastases identified on pre-treatment imaging.
16 maj 2023 · Prognosis. FAQs. Summary. High risk prostate cancer means that tumors may be at risk of spreading beyond the prostate or have already done so. Prostate cancers are divided into...
All patients had high-risk prostate cancer classified as PSA ≥20 ng/mL, Gleason score 8-10, or ≥T3 disease. The 10-year cancer-specific survival rates were 92%, 92%, and 88% for patients receiving radical prostatectomy, EBRT and ADT, and EBRT alone, respectively (p=0.06).
In the UK, doctors now divide localised and locally advanced prostate cancer into 5 risk groups. This is the Cambridge Prognostic Group (CPG). The 5 risk groups are from CPG1 to CPG5. Some doctors may still use an older system that divides prostate cancer into 3 risk groups. These are: low risk prostate cancer
Survival for all stages of prostate cancer. Generally for men with prostate cancer in England: more than 95 out of 100 (more than 95%) will survive their cancer for 1 year or more; around 90 out of 100 (around 90%) will survive their cancer for 5 years or more; almost 80 out of 100 (almost 80%) will survive their cancer for 10 years or more
14 mar 2024 · Marital status is an independent prognostic factor for survival in many types of cancers, but its prognostic impact on patients with prostate cancer (PCa) has not been established.
1 lis 2022 · Overall survival rates from prostate cancer are good, with a five-year survival rate of 98%. Even with stage IV prostate cancer, improvements in treatments have increased survival times and have led to a significant reduction in deaths related to prostate cancer.
